BIO vs FLEX · rev $2.58B vs P/E 23, rev $6.40B
BIO (BIO) versus Flex Ltd (FLEX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Flex Ltd (FLEX) is a electronic components company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
BIO currently screens at market cap $0. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Not investment advice. Open the BIO and FLEX stock pages for the full models.
Not investment advice.